Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Niemann-Pick Disease, Type C D052556 1 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Sensation Disorders D012678 2 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Ileus D045823 3 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Fabry Disease D000795 4 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Ovarian Diseases D010049 5 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Stahelin RV et al. The mechanism of membrane targeting of human sphingosine kinase 1. 2005 J. Biol. Chem. pmid:16243846
Hojjati MR et al. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. 2005 J. Biol. Chem. pmid:15590644
Davis MD et al. Sphingosine 1-phosphate analogs as receptor antagonists. 2005 J. Biol. Chem. pmid:15590668
Lee MS et al. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells. 2005 Am. J. Physiol., Cell Physiol. pmid:15590895
Watterson KR et al. The role of sphingosine-1-phosphate in smooth muscle contraction. 2005 Cell. Signal. pmid:15567060
Fieger CB et al. Type 1 sphingosine 1-phosphate G protein-coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino-terminal tyrosines. 2005 FASEB J. pmid:16148028
Hla T Immunology. Dietary factors and immunological consequences. 2005 Science pmid:16150998
Schwab SR et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. 2005 Science pmid:16151014
Urata Y et al. Sphingosine 1-phosphate induces alpha-smooth muscle actin expression in lung fibroblasts via Rho-kinase. 2005 Kobe J Med Sci pmid:16199931
Hughes SK et al. Fluid shear stress modulates cell migration induced by sphingosine 1-phosphate and vascular endothelial growth factor. 2005 Ann Biomed Eng pmid:16133909
Katkade V et al. Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through Akt. 2005 Thromb. Haemost. pmid:16268479
Wei SH et al. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. 2005 Nat. Immunol. pmid:16273098
Bandhuvula P et al. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. 2005 J. Biol. Chem. pmid:16118221
Kharel Y et al. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. 2005 J. Biol. Chem. pmid:16093248
Maceyka M et al. Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics. 2005 Prostaglandins Other Lipid Mediat. pmid:16099387
Danieli-Betto D et al. Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue. 2005 Am. J. Physiol., Cell Physiol. pmid:15659717
Roth Z and Hansen PJ Disruption of nuclear maturation and rearrangement of cytoskeletal elements in bovine oocytes exposed to heat shock during maturation. 2005 Reproduction pmid:15695618
Tanski WJ et al. Sphingosine-1-phosphate-induced smooth muscle cell migration involves the mammalian target of rapamycin. 2005 J. Vasc. Surg. pmid:15696050
Chun J Lysophospholipids in the nervous system. 2005 Prostaglandins Other Lipid Mediat. pmid:16099390
Rosen H Chemical approaches to the lysophospholipid receptors. 2005 Prostaglandins Other Lipid Mediat. pmid:16099402
Tani M et al. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. 2005 J. Lipid Res. pmid:16061940
Katsuma S et al. Transcriptional regulation of connective tissue growth factor by sphingosine 1-phosphate in rat cultured mesangial cells. 2005 FEBS Lett. pmid:15862293
Johnstone ED et al. Sphingosine-1-phosphate inhibition of placental trophoblast differentiation through a G(i)-coupled receptor response. 2005 J. Lipid Res. pmid:15995175
Rosen H and Goetzl EJ Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. 2005 Nat. Rev. Immunol. pmid:15999095
Yin F and Watsky MA LPA and S1P increase corneal epithelial and endothelial cell transcellular resistance. 2005 Invest. Ophthalmol. Vis. Sci. pmid:15914605
Karliner JS Off the shelf but not mass produced. 2005 Chem. Biol. pmid:15975506
Jo E et al. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. 2005 Chem. Biol. pmid:15975516
Li Z et al. Role of guanine nucleotide exchange factor P-Rex-2b in sphingosine 1-phosphate-induced Rac1 activation and cell migration in endothelial cells. 2005 Prostaglandins Other Lipid Mediat. pmid:15967165
Ledent C et al. Premature ovarian aging in mice deficient for Gpr3. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:15956199
Long J et al. Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools. 2005 Biochem. J. pmid:15960610
Malchinkhuu E et al. Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells. 2005 Oncogene pmid:16007180
Pébay A et al. Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. 2005 Nov-Dec Stem Cells pmid:16081668
Seol GH et al. Sphingosine-1-phosphate-induced intracellular Ca2+ mobilization in human endothelial cells. 2005 Sep-Dec Endothelium pmid:16410226
Huwiler A and Pfeilschifter J Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy. 2006 Curr. Pharm. Des. pmid:17168766
Zeidan YH et al. Acid ceramidase but not acid sphingomyelinase is required for tumor necrosis factor-{alpha}-induced PGE2 production. 2006 J. Biol. Chem. pmid:16803890
Dindo D et al. Cationic long-chain ceramide LCL-30 induces cell death by mitochondrial targeting in SW403 cells. 2006 Mol. Cancer Ther. pmid:16818511
Durand CA et al. The Rap GTPases mediate CXCL13- and sphingosine1-phosphate-induced chemotaxis, adhesion, and Pyk2 tyrosine phosphorylation in B lymphocytes. 2006 Eur. J. Immunol. pmid:16821235
Giussani P et al. Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of ceramide. 2006 Mol. Cell. Biol. pmid:16782891
Sanna MG et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. 2006 Nat. Chem. Biol. pmid:16829954
Veracini L et al. Two distinct pools of Src family tyrosine kinases regulate PDGF-induced DNA synthesis and actin dorsal ruffles. 2006 J. Cell. Sci. pmid:16787943
di Villa Bianca Rd et al. Sphingosine 1-phosphate induces endothelial nitric-oxide synthase activation through phosphorylation in human corpus cavernosum. 2006 J. Pharmacol. Exp. Ther. pmid:16234413
Bu S et al. Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts. 2006 FASEB J. pmid:16278291
Inniss K and Moore H Mediation of apoptosis and proliferation of human embryonic stem cells by sphingosine-1-phosphate. 2006 Stem Cells Dev. pmid:17253942
Matsuyuki H et al. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P. 2006 Cell. Mol. Immunol. pmid:17257496
Choueiri TK et al. Phenoxodiol: isoflavone analog with antineoplastic activity. 2006 Curr Oncol Rep pmid:16507219
Naetzker S et al. Activation of p38 mitogen-activated protein kinase and partial reactivation of the cell cycle by cis-4-methylsphingosine direct postmitotic neurons towards apoptosis. 2006 Genes Cells pmid:16483315
Jurisicova A et al. Molecular requirements for doxorubicin-mediated death in murine oocytes. 2006 Cell Death Differ. pmid:16439991
Bassi R et al. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors. 2006 Glia pmid:16470810
Yatomi Y Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. 2006 Curr. Pharm. Des. pmid:16472149
Kurobe H et al. CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance. 2006 Immunity pmid:16473829